Recent Blog Articles

Harvard Health Blog

A new hormonal therapy for prostate cancer is under expedited FDA review

July 13, 2020
  • By: Charlie Schmidt,

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

Comments

Jack fogarty
July 20, 2020

Can relugolix replace radiation treatment. Starting in 6 days

scotty
July 20, 2020

what does Relugolix do that Lupron doesn’t do? And is it any better for metastatic PC than Enzalutamide?
thanks

Commenting has been closed for this post.